Published in J Infect Dis on February 01, 1984
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Infections in solid-organ transplant recipients. Clin Microbiol Rev (1997) 2.86
Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible persons. J Clin Microbiol (1997) 1.52
Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation. J Clin Microbiol (2008) 1.20
Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev (2004) 1.19
Prevention of infection due to Pneumocystis carinii. Antimicrob Agents Chemother (1998) 1.11
Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation (1989) 1.02
Antimicrobial strategies in the care of organ transplant recipients. Antimicrob Agents Chemother (1993) 1.01
An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. Br J Cancer (2005) 0.97
Immunodetection of Pneumocystis carinii in bronchoalveolar lavage specimens compared with methenamine silver stain. J Clin Microbiol (1996) 0.81
Pneumocystis carinii pneumonia. Thorax (1985) 0.77
Late-onset and atypical presentation of Pneumocystis carinii pneumonia in a renal transplant recipient. Clin Exp Nephrol (2008) 0.76
Does cyclosporin A adversely affect Pneumocystis carinii infection? Postgrad Med J (1988) 0.75
Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial. Arthritis Res Ther (2017) 0.75
Evolution of liver transplantation. Hepatology (1982) 19.54
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
The epidemiology of AIDS: current status and future prospects. Science (1985) 8.73
Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet (2003) 6.23
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Epidemiology of HIV infection and AIDS in the United States. Science (1988) 5.53
Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med (1990) 5.15
Review of death certificates to assess completeness of AIDS case reporting. Public Health Rep (1987) 4.66
The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States. JAMA (1986) 4.60
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut (2002) 3.73
Regulation of cellular interferon production: enhancement by antimetabolites. Proc Natl Acad Sci U S A (1970) 3.66
Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation (1983) 3.60
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med (1992) 3.30
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med (1989) 3.13
The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med (1975) 3.09
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01
The incidence rate of acquired immunodeficiency syndrome in selected populations. JAMA (1985) 3.00
Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis (1991) 2.87
Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis (1988) 2.76
Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N Engl J Med (1993) 2.71
Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J Exp Med (1991) 2.59
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1990) 2.50
The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis (1999) 2.49
Opportunistic lung infection due to "Pittsburgh Pneumonia Agent". N Engl J Med (1979) 2.49
A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med (1989) 2.45
Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids. Surg Gynecol Obstet (1982) 2.42
Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother (2001) 2.41
Cyclosporine kinetics in renal transplantation. Clin Pharmacol Ther (1985) 2.38
The pathophysiology of malaria. Adv Parasitol (1992) 2.33
Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med (2001) 2.28
Circulating leptin levels during acute experimental endotoxemia and antiinflammatory therapy in humans. J Infect Dis (1998) 2.27
Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis (1986) 2.18
Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect Immun (1995) 2.05
Efficacy of cutting balloon angioplasty for lesions at the ostium of the coronary arteries. J Invasive Cardiol (1999) 2.04
Viral infections in renal transplant recipients. Infect Immun (1976) 2.03
HIV seroprevalence surveys in sexually transmitted disease clinics. Public Health Rep (1990) 2.02
Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. Ann Emerg Med (1998) 2.02
Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol (1983) 2.00
Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med (1994) 2.00
Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. JAMA (1990) 2.00
The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med (1997) 1.98
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford) (2005) 1.91
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. Lancet (1991) 1.89
Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis (1985) 1.88
Difficult thoracic lesions: CT-guided biopsy experience in 150 cases. Radiology (1988) 1.87
Malaria in splenectomized patients: report of four cases and review. Clin Infect Dis (1993) 1.85
Development of a quality of care measurement system for children and adolescents. Methodological considerations and comparisons with a system for adult women. Arch Pediatr Adolesc Med (1997) 1.78
Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol (1999) 1.77
A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy. J Infect Dis (2000) 1.71
Virus infections after transplantation in man. Brief review. Arch Virol (1977) 1.70
No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acquir Immune Defic Syndr (1990) 1.67
Reactivation of murine cytomegalovirus by cyclophosphamide. Nature (1977) 1.67
Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis (1990) 1.67
Early Function of Heart, Liver, and Kidney Allografts Following Combined Procurement. Transplant Proc (1984) 1.66
Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial. Crit Care Med (1996) 1.66
Induced sputum to diagnose Pneumocystis carinii pneumonia in immunosuppressed pediatric patients. J Pediatr (1989) 1.63
Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N Engl J Med (1979) 1.61
Interferon. Annu Rev Microbiol (1975) 1.61
Response of man to endotoxin. Immunobiology (1993) 1.60
Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol (1991) 1.57
Principles of multiple organ procurement from cadaver donors. Ann Surg (1983) 1.56
Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. J Virol (1989) 1.55
V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. Urology (2001) 1.54
Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow. Blood (2000) 1.54
Liver and kidney transplantation in children receiving cyclosporin A and steroids. J Pediatr (1982) 1.54
Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G(q)alpha-coupled phospholipase C-beta1. J Biol Chem (1997) 1.53
Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol (1999) 1.52
Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol (1988) 1.50
Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus. Infect Immun (1980) 1.50
Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA (1987) 1.49
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48
Serum vitamin D metabolites in very low birth weight infants with and without rickets and fractures. J Pediatr (1989) 1.47
Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis (1987) 1.47
Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay. J Clin Microbiol (1992) 1.46
Efficacy of cutting balloon angioplasty for in-stent restenosis: an intravascular ultrasound evaluation. J Invasive Cardiol (2001) 1.46
McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol (2001) 1.45
Hepatitis C virus. Another agent transmitted by transplanted organs. N Engl J Med (1991) 1.45
Cellular origin of interferon induced by bacterial lipopolysaccharide. Infect Immun (1977) 1.44
Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis (1985) 1.43
Efficacy of directional coronary atherectomy before stent implantation for coronary ostial lesions. J Invasive Cardiol (2000) 1.42
Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.41
Antibodies against haemorrhagic fever viruses in Kenya populations. Trans R Soc Trop Med Hyg (1983) 1.41
Accentuation of production of human interferon by metabolic inhibitors. Proc Soc Exp Biol Med (1972) 1.41
Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction. Science (1975) 1.40
Dynamic alteration in splenic function during acute falciparum malaria. N Engl J Med (1987) 1.40
Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions. J Immunol (1997) 1.39
Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother (2001) 1.38
Tolerance to the induction of interferons by endotoxin and virus: role of a humoral factor. Proc Soc Exp Biol Med (1965) 1.38
A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects. J Infect Dis (1978) 1.37
Resistance and susceptibility of mice to bacterial infection. IV. Genetic and cellular basis of resistance to chronic infection with Brucella abortus. J Infect Dis (1982) 1.34
Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. Br J Haematol (1987) 1.34
Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis (1991) 1.33